Di Tian1, Ziqi Xiong1, Yifan He1, Jingyu Zhang1, and Zhiyong Li1
1Department of Radiology, The First Affiliated Hospital of Dalian Medical University, Dalian, China, Dalian, China
Synopsis
Keywords: Cardiomyopathy, Cardiomyopathy
Myocardial fibrosis causes functional impairment in patients
with hypertrophic cardiomyopathy (HCM). The clinical gold standard for imaging
myocardial fibrosis is cardiac magnetic resonance imaging (MRI) with late gadolinium
enhancement (LGE), which is commonly used for the diagnosis and prognostic
evaluation of patients with HCM. However, LGE imaging is an invasive test and
some patients have adverse reactions to contrast agents. The aim of this study
is to predict the presence of fibrosis in the left ventricular myocardium by
cardiac magnetic resonance (CMR) non-invasive assessment of left atrial and
left ventricular parameters in patients with HCM.
Purpose
The
aim of this study is to predict the presence of fibrosis in the left
ventricular myocardium by cardiac magnetic resonance (CMR) non-invasive
assessment of left atrial and left ventricular parameters in patients with HCM.Introduction
Myocardial fibrosis causes functional impairment in patients
with hypertrophic cardiomyopathy (HCM). The clinical gold standard for imaging
myocardial fibrosis is cardiac magnetic resonance imaging (MRI) with late
gadolinium enhancement (LGE), which is commonly used for the diagnosis and
prognostic evaluation of patients with HCM [1-2]. However, LGE imaging is an
invasive test and some patients have adverse reactions to contrast agents. The
aim of this study is to predict the presence of fibrosis in the left
ventricular myocardium by cardiac magnetic resonance (CMR) non-invasive
assessment of left atrial and left ventricular parameters in patients with HCM.Material and Methods
Seventy-two patients with HCM were retrospectively included, all of whom
underwent 3.0T CMR and were stratified according to LGE. Cine images of the LV
short axis were acquired for analysis of LV parameters. LA volume (LAV) is
calculated using the two-plane area-length method[3]. LAV includes minimum LAV
(LAVmin), maximum LAV (LAVmax), and pre-contraction LAV (LAVpre-ac). LA strain
parameters were derived from CMR two- and four-chamber cine images by a
semiautomatic method. LA strain parameters include global longitudinal strain
(GLS) and global circumferential strain (GCS). The LA GLS includes reservoir
strain (GLS reservoir), conduit strain (GLS conduit), and booster strain (GLS
booster). Three LA GLS strain rate (SR) parameters were derived: SR reservoir,
SR conduit, and SR booster. Left ventricular short-axis late gadolinium
enhancement (LGE) images were obtained after 7-10 minutes of gadopentetate
glucosamine injection.RESULTS
LVEF,
LVSV, Passive LAEF, and SR Conduit were significantly lower in the LGE (+)
group compared with the HCM LGE (-) group (P < 0.05) (Tables 1 and
Table 2). The diagnostic performance of LA SR conduit to differentiate the
presence or absence of fibrosis in HCM myocardium (AUC = 0.681) was superior to
conventional LV and LA parameters (Figure 1A). The combined LVEF, LVSV, LAEF
passive and LA SR conduit model had the best diagnostic performance with an AUC
of 0.740 (Figure 1A and B).CONCLUSION
Noninvasive
assessment of LV and LA parameters by CMR in patients with HCM may predict the
presence or absence of fibrosis in the LV myocardium.Acknowledgements
No acknowledgementsReferences
[1]Moravsky G, Ofek E, Rakowski H, Butany J, Williams L, Ralph-Edwards A, Wintersperger BJ, Crean A. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. JACC Cardiovasc Imaging. 2013 May;6(5):587-96. doi: 10.1016/j.jcmg.2012.09.018.
[2]Song Y, Bi X, Chen L, Yang K, Chen X, Dong Z, Wang J, Kong X, Zhao K, Wang H, Duru F, Lu M, Ma L, Qiao S, Zhao S. Reduced myocardial septal function assessed by cardiac magnetic resonance feature tracking in patients with hypertrophic obstructive cardiomyopathy: associated with histological myocardial fibrosis and ventricular arrhythmias. Eur Heart J Cardiovasc Imaging. 2022 Jul 21;23(8):1006-1015. doi: 10.1093/ehjci/jeac032.
[3]Peters
DC, Lamy J, Sinusas AJ, Baldassarre LA. Left Atrial Evaluation by
Cardiovascular Magnetic Resonance: Sensitive and Unique Biomarkers. Eur Heart J Cardiovasc Imaging (2021)
23(1):14-30. Epub 2021/11/01. doi: 10.1093/ehjci/jeab221.